Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma-Reference-Cited by-同舟云学术

Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma

Published:2024-08 Issue:8 Volume:36 Page:1696-1710.e10
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Li Guanzhang,Wang Di,Zhai You,Pan Changqing,Zhang Jiazheng,Wang Chen,Huang Ruoyu,Yu Mingchen,Li Yiming,Liu Xing,Liu Yanwei,Wu Fan,Zhao Zheng,Hu Huimin,Shi Zhongfang,Kahlert Ulf Dietrich,Jiang Tao,Zhang Wei

Funder

National Key Research and Development Program of China Stem Cell and Translational Research

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference80 articles.

1. The 2021 WHO classification of tumors of the central nervous system: a summary;Louis;Neuro Oncol.,2021

2. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019;Ostrom;Neuro Oncol.,2022

3. Cancer statistics in China, 2015;Chen;CA. Cancer J. Clin.,2016

4. Clinical practice guidelines for the management of adult diffuse gliomas;Jiang;Cancer Lett.,2021

5. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in a novel model of autophagy and immune network regulation in radioresistance of cancer stem cells;Biomedicine & Pharmacotherapy;2024-10

2. Lactylation: Linking the Warburg effect to DNA damage repair;Cell Metabolism;2024-08